Literature DB >> 1752963

Fatty acids in the portal vein of the rat regulate hepatic insulin clearance.

J Svedberg1, G Strömblad, A Wirth, U Smith, P Björntorp.   

Abstract

The effects of FFA on hepatic insulin clearance were studied in the in situ perfused rat liver. Clearance decreased with increasing body weight (age) of the rats. When FFA were added to the perfusate a 40% reduction of hepatic removal of insulin was found over the normal, physiological range (less than 1,000 mumol/liter), less pronounced in heavier rats. When perfusion was started with high concentrations of FFA, inhibition was rapidly reversible, a phenomenon again blunted in heavier rats. In contrast to FFA, different glucose concentrations in the perfusate did not affect the hepatic insulin uptake in the presence of FFA within physiological concentrations. Thus, hepatic clearance of insulin is proportional to rat weight (age) and portal FFA concentrations. Other studies have recently shown that fatty acids inhibit insulin binding, degradation, and function in isolated rat hepatocytes, and that hepatic clearance is inversely dependent on hepatic triglyceride concentrations, both inhibitions reversible by prevention of fatty acid oxidation. It is suggested that the diminished hepatic clearance of insulin in heavier (older) rats is at least partly due to their relative obesity and increased hepatic triglyceride contents. This effect as well as that of portal FFA is probably mediated via fatty acid oxidation in the liver. This mechanism may have implications for the regulation of hepatic metabolism, and peripheral insulin concentrations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1752963      PMCID: PMC295800          DOI: 10.1172/JCI115534

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  A relation between non-esterified fatty acids in plasma and the metabolism of glucose.

Authors:  V P DOLE
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808

2.  Receptor and postreceptor effects of free fatty acids (FFA) on hepatocyte insulin dynamics.

Authors:  M M Hennes; E Shrago; A H Kissebah
Journal:  Int J Obes       Date:  1990-10

Review 3.  The kinetics of insulin in man. II. Role of the liver.

Authors:  E Ferrannini; C Cobelli
Journal:  Diabetes Metab Rev       Date:  1987-04

4.  Plasma insulin after diversion of portal and pancreatic venous blood to vena cava.

Authors:  W R Waddell; K E Sussman
Journal:  J Appl Physiol       Date:  1967-04       Impact factor: 3.531

5.  Metabolism of adipose tissue in intraabdominal depots in severely obese men and women.

Authors:  M Rebuffé-Scrive; B Anderson; L Olbe; P Björntorp
Journal:  Metabolism       Date:  1990-10       Impact factor: 8.694

6.  Peripheral insulin parallels changes in insulin secretion more closely than C-peptide after bolus intravenous glucose administration.

Authors:  E T Shapiro; H Tillil; A H Rubenstein; K S Polonsky
Journal:  J Clin Endocrinol Metab       Date:  1988-11       Impact factor: 5.958

7.  Prevention of inhibitory effect of free fatty acids on insulin binding and action in isolated rat hepatocytes by etomoxir.

Authors:  J Svedberg; P Björntorp; P Lönnroth; U Smith
Journal:  Diabetes       Date:  1991-06       Impact factor: 9.461

8.  Splanchnic insulin metabolism in obesity. Influence of body fat distribution.

Authors:  A N Peiris; R A Mueller; G A Smith; M F Struve; A H Kissebah
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

9.  Metabolism of adipose tissue in intraabdominal depots of nonobese men and women.

Authors:  M Rebuffé-Scrive; B Andersson; L Olbe; P Björntorp
Journal:  Metabolism       Date:  1989-05       Impact factor: 8.694

10.  Quantitative study of insulin secretion and clearance in normal and obese subjects.

Authors:  K S Polonsky; B D Given; L Hirsch; E T Shapiro; H Tillil; C Beebe; J A Galloway; B H Frank; T Karrison; E Van Cauter
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

View more
  19 in total

Review 1.  Abdominal adipose tissue distribution and metabolic risk.

Authors:  Suzy Wong; Ian Janssen; Robert Ross
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 2.  Abdominal obesity: a marker of ectopic fat accumulation.

Authors:  Ulf Smith
Journal:  J Clin Invest       Date:  2015-05-01       Impact factor: 14.808

3.  Dehydroepiandrosterone alters lipid profiles in Zucker rats.

Authors:  J M Abadie; G T Malcom; J R Porter; F Svec
Journal:  Lipids       Date:  2000-06       Impact factor: 1.880

4.  Relationships of generalized and regional adiposity to insulin sensitivity in men.

Authors:  N Abate; A Garg; R M Peshock; J Stray-Gundersen; S M Grundy
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

5.  Association of apolipoprotein B with incident type 2 diabetes in an aboriginal Canadian population.

Authors:  Sylvia H Ley; Stewart B Harris; Philip W Connelly; Mary Mamakeesick; Joel Gittelsohn; Thomas M Wolever; Robert A Hegele; Bernard Zinman; Anthony J Hanley
Journal:  Clin Chem       Date:  2010-01-28       Impact factor: 8.327

6.  Glucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPARalpha and FGF21 transcripts in vivo.

Authors:  Eric D Berglund; Li Kang; Robert S Lee-Young; Clinton M Hasenour; Daniel G Lustig; Sara E Lynes; E Patrick Donahue; Larry L Swift; Maureen J Charron; David H Wasserman
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-07-27       Impact factor: 4.310

7.  Parallel manifestation of insulin resistance and beta cell decompensation is compatible with a common defect in Type 2 diabetes.

Authors:  D Tripathy; K F Eriksson; M Orho-Melander; J Fredriksson; G Ahlqvist; L Groop
Journal:  Diabetologia       Date:  2004-04-28       Impact factor: 10.122

8.  Lipid infusion lowers sympathetic nervous activity and leads to increased beta-cell responsiveness to glucose.

Authors:  C Magnan; S Collins; M F Berthault; N Kassis; M Vincent; M Gilbert; L Pénicaud; A Ktorza; F Assimacopoulos-Jeannet
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

9.  Insulin concentrations and insulin sensitivity after short-term amiloride in healthy subjects.

Authors:  J W Eriksson; J Fowelin; V Urbanavicius
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

10.  Lipotoxicity: effects of dietary saturated and transfatty acids.

Authors:  Débora Estadella; Claudia M da Penha Oller do Nascimento; Lila M Oyama; Eliane B Ribeiro; Ana R Dâmaso; Aline de Piano
Journal:  Mediators Inflamm       Date:  2013-01-31       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.